Finch Therapeutics Group Inc. Gains 41.45%
Mon, Jun 12, 2023 at 07:39 PM
Finch Therapeutics Group Inc. (FNCH:NASDAQ) soared at $11.5, a gain of 41.4%. On Mon, Jun 12, 2023, FNCH:NASDAQ hit a New 2-Week High of $11.5. The stock got featured on our News Catalysts scanner on Fri, Jun 09, 2023 at 08:47 AM in the 'SPLIT' category. From Tue, May 30, 2023, the stock recorded 22.22% Up Days and 50.00% Green Days
The stock spiked on Mon, Jun 12, 2023 at $16.74 with a volume of 1M+.
About Finch Therapeutics Group Inc. (FNCH:NASDAQ)
Finch Therapeutics Group Inc is a clinical-stage microbiome therapeutics company. It is leveraging Human-First Discovery platform to develop a novel class of orally administered biological drugs.
Top 10 Gainers:
- Viveve Medical, Inc. (VIVE:NASDAQ), 5542.86%
- Auddia Inc. (AUUD:NASDAQ), 181.5%
- Asset Entities Inc. (ASST:NASDAQ), 75.65%
- Chinook Therapeutics Inc. (KDNY:NASDAQ), 58.32%
- Unico American Corporation (UNAM:NASDAQ), 55.68%
- Appreciate Holdings Inc Cl A (SFR:NASDAQ), 55.13%
- JIN MEDICAL INTERNATIONAL LTD. (ZJYL:NASDAQ), 54.75%
- Lottery.com Inc. (LTRY:NASDAQ), 51.57%
- Finch Therapeutics Group Inc. (FNCH:NASDAQ), 41.45%
- Accelerate Diagnostics, Inc. (AXDX:NASDAQ), 39.19%